Trials Consider Role of Immunotherapy in Breast Cancer

2018-03-29 10:16:32

Mixed results have occured in recent trials testing immuotherapy in patients with breast cancer. Checkpoint inhibitors have been used as monotherapy in a pair of trials, reporting lackluster overall response rates. When immunotherapy was paired with chemotherapy, on the other hand, it usually revealed better results, and gave signals that immunotherapies combined with targeted agents could work better than immunotherapy alone.


  • Save
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply